What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
Autor: | Seibyl JP; From the Institute for Neurodegenerative Disorders (J.P.S.), New Haven, CT; Department of Radiology (P.K.), University of Arizona, Tucson; and Invicro, LLC (P.K.), New Haven, CT. jseibyl@indd.org., Kuo P; From the Institute for Neurodegenerative Disorders (J.P.S.), New Haven, CT; Department of Radiology (P.K.), University of Arizona, Tucson; and Invicro, LLC (P.K.), New Haven, CT. |
---|---|
Jazyk: | angličtina |
Zdroj: | Neurology [Neurology] 2022 Aug 16; Vol. 99 (7 Suppl 1), pp. 61-67. |
DOI: | 10.1212/WNL.0000000000200786 |
Databáze: | MEDLINE |
Externí odkaz: |